| PERIOD ENDING | 4-Oct-09 | 5-Jul-09 | 5-Apr-09 | 4-Jan-09 | | Total Revenue | 47,248 | 45,227 | 48,459 | 52,786 | | Cost of Revenue | 18,760 | 32,595 | 20,785 | 21,598 | | | Gross Profit | 28,488 | 12,632 | 27,674 | 31,188 | | | Operating Expenses | | Research Development | 14,839 | 15,326 | 16,393 | 14,851 | | Selling General and Administrative | 13,196 | 13,659 | 13,490 | 15,714 | | Non Recurring | 175 | 5,594 | 1,119 | 2,424 | | Others | 193 | 192 | 193 | 338 | | | | Total Operating Expenses | 28,403 | 34,771 | 31,195 | 33,327 | | | | Operating Income or Loss | 85 | (22,139) | (3,521) | (2,139) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 776 | 1,752 | 1,335 | | Earnings Before Interest And Taxes | 749 | (21,363) | (1,769) | (804) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 749 | (21,363) | (1,769) | (804) | | Income Tax Expense | (157) | 23,778 | 1,187 | 11,688 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 906 | (45,141) | (2,956) | (12,492) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 906 | (45,141) | (2,956) | (12,492) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $906 | ($45,141) | ($2,956) | ($12,492) |
|
0.11% Nasdaq 0.00%
Income Statement
